HYH Fundamental Analysis - HALYARD HEALTH INC

No Fundamental Analysis report for HYH not available.

HALYARD HEALTH INC

NYSE:HYH (6/29/2018, 8:04:04 PM)

After market: 57.25 0 (0%)

57.25

+0.04 (+0.07%)

Chartmill FA Rating

GICS SectorN/A

GICS IndustryGroupN/A

GICS IndustryN/A

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst Owners90.24%

Inst Owner Change0%

Ins Owners0.2%

Ins Owner Change0%

Market Cap2.69B

Revenue(TTM)1.12B

Net Income(TTM)86.70M

AnalystsN/A

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly Dividend0

Dividend Growth(5Y)0%

DP0%

Div Incr YearsN/A

Div Non Decr YearsN/A

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	22.02
Fwd PE	35.34
P/S	2.4
P/FCF	N/A
P/OCF	N/A
P/B	2.15
P/tB	N/A
EV/EBITDA	30.58

EPS(TTM)2.6

EY4.54%

EPS(NY)1.62

Fwd EY2.83%

FCF(TTM)N/A

FCFYN/A

OCF(TTM)N/A

OCFYN/A

SpS23.89

BVpS26.62

TBVpSN/A

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	3.94%
ROE	6.93%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	7.72%
GM	N/A
FCFM	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3Y0%

ROICexgc growth 5Y0%

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score7

Asset Turnover0.51

Health

		Industry Rank	Sector Rank
Debt/Equity	0.43
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	3.22
Quick Ratio	2.96
Altman-Z	2.44

F-Score7

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)19.29%

EPS 3YN/A

EPS 5Y-6.86%

EPS Q2Q%58.33%

EPS Next Y-25.53%

EPS Next 2Y-16.97%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)243.41%

Revenue growth 3YN/A

Revenue growth 5Y-7.71%

Sales Q2Q%7.34%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1YN/A

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1YN/A

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1YN/A

OCF growth 3YN/A

OCF growth 5YN/A

HALYARD HEALTH INC / HYH FAQ

What is the ChartMill fundamental rating of HALYARD HEALTH INC (HYH) stock?

ChartMill assigns a fundamental rating of 4 / 10 to HYH.

Can you provide the valuation status for HALYARD HEALTH INC?

ChartMill assigns a valuation rating of 3 / 10 to HALYARD HEALTH INC (HYH). This can be considered as Overvalued.

What is the profitability of HYH stock?

HALYARD HEALTH INC (HYH) has a profitability rating of 5 / 10.

What is the valuation of HALYARD HEALTH INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for HALYARD HEALTH INC (HYH) is 22.02 and the Price/Book (PB) ratio is 2.15.

How sustainable is the dividend of HALYARD HEALTH INC (HYH) stock?

The dividend rating of HALYARD HEALTH INC (HYH) is 0 / 10 and the dividend payout ratio is 0%.